1609102-49-9

Basic information

• Product Name: C₃₇H₄₉FN₄O₃
• Synonyms: C₃₇H₄₉FN₄O₃
• CAS NO: 1609102-49-9
• Molecular Weight: 616.819
• Mol File: 1609102-49-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₇H₄₉FN₄O₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₇H₄₉FN₄O₃(1609102-49-9)
• EPA Substance Registry System: C₃₇H₄₉FN₄O₃(1609102-49-9)

Safety Data

• Hazardous Substances Data: 1609102-49-9(Hazardous Substances Data)

Upstream product

• 10417-94-4 all cis-5,8,11,14,17-eicosapentaenoic acid 
• 1609102-48-8 C₁₇H₂₁FN₄O₂ 
• 24424-99-5 di-tert-butyl dicarbonate 
• 33400-49-6 2-amino-3-nitro-6-(p-fluoro-benzylamino)-pyridine 
• 1609102-47-7 3-nitro-6-p-fluorobenzylaminopyridin-2-ylaminoformic acid tert-butyl ester 

Downstream Products

• 1482053-40-6 C₃₂H₄₁FN₄O 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN AND NEUROLOGICAL DISEASES

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of pain and neurological diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of partial-onset seizures, diabetic neuropathic pain, back pain and other orthopaedic uses, migraines, oncology, postoperative care, gynaecology, Creutzfeld- Jakob disease, multiple sclerosis, Batten disease, fibromyalgia, Alzheimer's disease, and multiple sclerosis.